immunity News and Research

RSS

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.

1 Mar 2024

Scientists discover a key mechanism used by human herpesvirus 8 to induce cancer

Cleveland Clinic researchers have discovered a key mechanism used by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer.

1 Mar 2024

Newly identified antibodies target a hard-to-spot region of the influenza virus

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.

1 Mar 2024

Corticosteroids may restore sense of smell in COVID-19 patients

COVID-19 is known to cause loss of smell in certain patients. While this symptom is generally temporary, approximately 10% of patients may suffer from it for 6 months or more.

29 Feb 2024

Breakthrough CRISPR technique unlocks insights about cancer immunology

Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer.

29 Feb 2024

New approach detects T cells in "cold" tumors, paves way for broader immunotherapy

Most cancers are thought to evade the immune system. These cancers don't carry very many mutations, and they aren't infiltrated by cancer-fighting immune cells. Scientists call these cancers immunologically "cold."

29 Feb 2024

Machine learning unveils key molecular players and immune signatures in stress cardiomyopathy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Stress cardiomyopathy (SCM) is a reversible, self-limiting condition that manifests as left ventricular insufficiency.

28 Feb 2024

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program "Covid-19," NRP 78) and the German Research Foundation (DFG) "Recoding the SARS-CoV-2 Genome - A Multidisciplinary Approach to Generate Live-Attenuated Coronavirus Vaccines."

27 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Study finds October-born kids less likely to catch flu post-vaccination

Study shows October as the optimal month for influenza vaccination in young children, aligning with CDC guidelines to maximize protection against seasonal flu.

26 Feb 2024

Study reveals BCG vaccine's unexpected role in fighting influenza

As Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses.

26 Feb 2024

Zika virus detected in Singapore neighborhood: 15 cases spark renewed vigilance

Entomological, wastewater, and case surveillance of the Zika virus (ZIKV) in Singapore.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Newborn T cells found to excel in immune defense

Scientists have long believed that a newborn's immune system was an immature version of an adult's, but new research from Cornell University shows that newborns' T cells – white blood cells that protect from disease – outperform those of adults at fighting off numerous infections.

24 Feb 2024

immunity News and Research

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

Scientists discover a key mechanism used by human herpesvirus 8 to induce cancer

Newly identified antibodies target a hard-to-spot region of the influenza virus

Corticosteroids may restore sense of smell in COVID-19 patients

Breakthrough CRISPR technique unlocks insights about cancer immunology

New approach detects T cells in "cold" tumors, paves way for broader immunotherapy

Machine learning unveils key molecular players and immune signatures in stress cardiomyopathy

Study shows the benefits of locally administered intranasal live-attenuated SARS-CoV-2 vaccine

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Study finds October-born kids less likely to catch flu post-vaccination

Study reveals BCG vaccine's unexpected role in fighting influenza

Zika virus detected in Singapore neighborhood: 15 cases spark renewed vigilance

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Newborn T cells found to excel in immune defense

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Genetic signature may help predict disease-free survival in patients with non-small cell lung cancer

Yale School of Medicine secures $575,000 grant for Long COVID research

Research reveals bacteria's dynamic defense duo against phage viruses

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids to school

Natural killer cells lead the charge in cancer treatment innovation

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News